Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity [WGBS]

ABSTRACT: Tumor heterogeneity is the substrate for tumor evolution and the linchpin of treatment resistance. The widespread epigenome repatterning that characterizes most cancers can generate cells with diverse identities and malignant features; however, how this occurs is not known. We show that high levels of the epigenetic regulator and oncogene UHRF1 in zebrafish hepatocytes rapidly induce disordering of the DNA methylome, loss of heterochromatin, and DNA damage, resulting in cell cycle arrest, atm-tp53-mediated senescence, and acquisition of stemness. Most cells are eliminated, but some in which UHRF1 expression is reduced transition to proliferation-competent cells, generating heterogeneous tumors comprised of cancer cells with progenitor-like features and persistently senescent cells that serve as reservoirs for new cancer cells. The gene signature from UHRF1-driven zebrafish tumors defines an immature and aggressive hepatocellular carcinoma subclass in humans. This defines epigenetic disordering, stemness, and senescence escape as requisite steps in developing aggressive and immature liver tumors.

ORGANISM(S): Danio rerio

PROVIDER: GSE303273 | GEO | 2026/09/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity [scRNAseq_hUHRF1]

Project description:Heterogeneity is largely attributed to distinct genetic changes within each cell population but the widespread epigenome repatterning that characterizes most cancers is also highly heterogenous within tumors, and can generate cells with diverse identities and malignant features. We show that high levels of the epigenetic regulator and oncogene, UHRF1, in zebrafish hepatocytes rapidly induced methylome disordering, loss of heterochromatin, and DNA damage, resulting in cell cycle arrest, senescence, and acquisition of stemness. Reducing UHRF1 expression transitions these cells from senescent to proliferation-competent. The expansion of these damaged cells results in hepatocellular carcinomas (HCC) that have immature cancer cells intermingled with fibroblasts, immune and senescent cells expressing high UHRF1 levels, which serve as reservoirs for new cancer cells. Here, we performed scRNAseq in zebrafish livers with UHRF1 overexpressing hepatocytes and controls, in which membrane ocalized EGFP was expressed, at time points in which we observe senescence, senescence escape and HCC formation.

2026-08-25 | GSE303361 | GEO

Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity bulk RNAseq

Project description:Heterogeneity is largely attributed to distinct genetic changes within each cell population but the widespread epigenome repatterning that characterizes most cancers is also highly heterogenous within tumors, and can generate cells with diverse identities and malignant features. We show that overexpressing high levels of the epigenetic regulator and oncogene, human UHRF1, in zebrafish hepatocytes rapidly induced changes in the DNA methylome and disordering, DNA damage, cell cycle arrest, senescence, and acquisition of progenitor like features. These changes are observed within 1 day of human UHRF1 overexpression (at 80 hours post fertilization; hpf) and is fully evident at 120 hpf. Reducing UHRF1 expression transitions these cells from senescent to proliferation-competent. Removing demonstrated that UHRF1 overexpression at 80 hpf already induced DNA damage response, senescence and decrease of hepatocyte specific pathways and this is further exhanced at 120 hpf. Deletion of tp53 from UHRF1 overexpressing line completely rescued cellular senescence and some of the key senescence-associated genes but do not abrograte the major transcriptomic changes caused by UHRF1 overexpression.

2026-08-25 | GSE302812 | GEO

Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity [WGBS]

Project description:Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity [WGBS]

| PRJNA1294733 | ENA

Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity [scRNAseq_hUHRF1]

Project description:Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity [scRNAseq_hUHRF1]

| PRJNA1294898 | ENA

Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity bulk RNAseq

Project description:Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor Heterogeneity bulk RNAseq

| PRJNA1292203 | ENA

DNA methylation protects cancer cells against non-canonical senescence

Project description:Aberrant DNA methylation patterns are a hallmark of human cancers, prompting targeting of DNA methylation machinery to be explored as an anti-tumor strategy. DNA methyltransferase 1 (DNMT1) and ubiquitin like With PHD and Ring finger domains 1 (UHRF1) are crucial enzymes for DNA methylation maintenance. Unlike DNMT1, UHRF1 is overexpressed in most cancers and is a proven oncogene in vivo. Our previous work revealed that the degree of DNA methylation loss induced by UHRF1 depletion is more severe than DNMT1 depletion in colorectal cancer cells, indicating that targeting UHRF1 may be a more effective approach. Using an advanced chemical/genetic system, the auxin-inducible degron (AID) technology, we monitored the long-term effects of removing UHRF1 and/or DNMT1 in cancer cells, deciphering the mechanistic basis through bioinformatic tools. We found that chronic DNA demethylation triggers cancer cells to undergo cellular senescence. The loss of UHRF1 results in a more rapid and profound senescence phenotype than DNMT1 loss. Intriguingly, this senescence is not accompanied by DNA damage and functions independently of canonical senescence pathways such as p53 and p16/pRB. Non-canonical pathway investigations revealed that cytosolic p21 accumulation contributes to antiapoptosis during senescence. The suppression of cyclic GMP-AMP synthase (cGAS) also alleviates the senescence-associated secretory phenotype (SASP) and lysosomal activity, and this process is independent of stimulator of interferon genes (STING). Finally, xenograft experiments verified our findings in vivo. Our results highlight how DNA methylation protects cancer cells from non-canonical senescence and demonstrate the potential of targeting UHRF1 as a novel avenue for anticancer treatments.

2025-05-19 | GSE278681 | GEO

DNA methylation protects cancer cells against non-canonical senescence

2025-05-19 | GSE278103 | GEO

Expression data of MB49-PBS and MB49-Glucose tumor-infiltrating CD4+ T cells

Project description:Glucose-treated Th9 cells in MB49 tumors significantly reduced T cell senescence while enhancing T cell stemness and effector function.

2026-10-02 | GSE327338 | GEO

Critical role of the UBL-domain in stimulating the E3 ubiquitin ligase activity of UHRF1 towards chromatin

Project description:The RING E3 ubiquitin ligase UHRF1 controls DNA methylation through its ability to target the maintenance DNA methyltransferase DNMT1 to newly replicated chromatin. DNMT1 recruitment relies on ubiquitylation of histone H3 by UHRF1, however, how UHRF1 deposits ubiquitin onto the histone is unknown. Here, we demonstrate that the ubiquitin-like domain (UBL) of UHRF1 is essential for RINGmediated H3 ubiquitylation. Using chemical crosslinking and mass spectrometry, biochemical assays and recombinant chromatin substrates we show that the UBL participates in structural rearrangements of UHRF1 upon binding to chromatin and the E2 ubiquitin conjugating enzyme UbcH5a/UBE2D1. Similar to ubiquitin, the UBL exerts its effects through a hydrophobic patch that contacts a regulatory surface on the “backside” of the E2 to stabilise the E2-E3-chromatin complex. Our analysis of the enzymatic mechanism of UHRF1 uncovers an unexpected function of the UBLdomain and defines a new role for this domain in DNMT1-dependent inheritance of DNA methylation.

2018-11-04 | PXD011510 | Pride

Mus musculus

Project description:Stemness of p57+ cells in intestinal tumors

| PRJDB14125 | ENA